Comparing Optical Coherence Tomography (OCT) and Visual Acuity Outcomes in Subjects Undergoing Cataract Surgery, Who Receive Xibrom Ophthalmic Solution and Standard Presurgical Care vs. Xibrom Ophthalmic Solution Plus Prednisolone Acetate 1% and Standard Presurgical Care

Inclusion Criteria: * Male or female at least 18 years of age. * Expectation of 20/25 best corrected visual acuity (BCVA) post-operatively. * Patients should be in good general health and devoid of recognized risk factors for CME. * Patients with systemic diseases are eligible only if there were no ocular manifestations of the disease (specifically diabetics without retinopathy) * Patients must be likely to provide informed consent, take study medications as directed, and complete all study visits * Only one eye of each treated patient may be included in the study Exclusion Criteria: * Any known contraindications to any study medication or their component * Presence of uncontrolled systemic disease * Required use of other ocular medications during the study o Artificial tears may be used * Diabetics with any clinically evident or history of retinopathy * Individuals with age-related macular changes, epi-retinal membranes, other retino-vascular diseases and/or other macular disorders thought to have a less than 20/25 surgical outcome expectation * Abnormal pre-operative OCT (if obtainable)